[144] Bristol-Myers Squibb Co. SEC Filing

Rhea-AI Filing Summary

Bristol-Myers Squibb Co. (BMY) filed a Form 144 notifying the proposed sale of 56,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $2,648,800.00. The filing reports total shares outstanding of 2,035,435,838 and an approximate sale date of 09/02/2025. The shares to be sold were acquired over 2021–2023 through stock option exercises and restricted stock vesting, with acquisition amounts listed by date (e.g., 2,976 on 08/12/2021; 19,326 on 09/13/2022). No securities were reported sold in the past three months.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an insider sale of 56,000 shares (approximate value $2.65M) sourced from prior compensation and option exercises.

The filing documents a proposed sale through Fidelity on the NYSE with explicit acquisition history showing stock option exercises and restricted stock vesting across 2021–2023. The size of the sale relative to total outstanding shares (2,035,435,838) is small. There are no reported sales in the prior three months, and the filer affirms no undisclosed material adverse information. Impact appears procedural rather than company-changing.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements and identifies compensation-related share sources, indicating compliance-focused reporting.

The schedule breaks down the origin of shares (option exercises and vesting) with dates and amounts, which supports transparency about the insider's basis and timing. The filing includes the standard representation regarding material nonpublic information and does not indicate reliance on a 10b5-1 plan in the remarks. This is a routine insider sale notice with limited material impact on governance or capitalization.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	56000	2648800.00	2035435838	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2021	Stock Option Exercise	Issuer			2976	08/12/2021	Cash
Common	03/01/2022	Restricted Stock Vesting	Issuer			14196	03/01/2022	Compensation
Common	03/10/2022	Restricted Stock Vesting	Issuer			8807	03/10/2022	Compensation
Common	09/13/2022	Stock Option Exercise	Issuer			19326	09/13/2022	Cash
Common	12/02/2022	Restricted Stock Vesting	Issuer			4294	12/02/2022	Compensation
Common	03/10/2023	Restricted Stock Vesting	Issuer			6401	03/10/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the BMY Form 144 propose to sell?

The notice proposes sale of 56,000 shares of common stock.

Through which broker will the BMY shares be sold?

The filing lists Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI) as the broker.

What is the aggregate market value and planned sale date in the BMY Form 144?

Aggregate market value is $2,648,800.00 with an approximate sale date of 09/02/2025.

How many BMY shares are outstanding according to the filing?

The filing reports 2,035,435,838 shares outstanding.

What were the sources of the shares listed in the Form 144?

Shares were acquired via stock option exercises and restricted stock vesting between 08/12/2021 and 03/10/2023, with specific amounts listed per date.

Did the filer report any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.